This protocol is judged by an institutional review board, an independent team that assessments any scientific trials involving individuals. If a study includes a Agenda I drug, after the board approves the protocol as ethical, the scientists need to apply for an investigational new drug (IND) quantity from the FDA.copyright first turned well known